Home / Inspections / 1253788

FDA Inspection 1253788 — Evonik Corporation

Evonik Corporation — FEI 1813682

The FDA completed an inspection of Evonik Corporation on September 11, 2025 in Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lafayette, IN (United States)

Facility

Other inspections at this facility

  • 1116380 (NAI Thu Jan 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041903 (NAI Fri Jan 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 937143 (NAI Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895822 (NAI Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 773708 (NAI Fri Mar 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources